Holen Sie sich die Stockscreener-App
6.10
3.79%
-0.24
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
9.97%
30.75
|
27.96 | 21.90 | 22.18 | 22.88 |
| Operating Income/Loss |
37.87%
-48.07
|
-34.87 | -27.24 | -27.91 | -28.61 |
| Nonoperating Income/Loss |
106.46%
2.461
|
1.192 | 1.693 | 1.802 | 1.642 |
| Income/Loss From Continuing Operations Before Tax |
35.44%
-45.61
|
-33.67 | -25.54 | -26.10 | -27.02 |
| Income Tax Expense/Benefit |
163.64%
0.029
|
0.011 | 0.015 | 0.026 | 0.048 |
| Net Income/Loss |
35.48%
-45.64
|
-33.69 | -25.56 | -26.13 | -27.02 |
| Basic Average Shares |
40.65%
94.86
|
67.45 | - | 65.94 | 58.02 |
| Diluted Average Shares |
40.65%
94.86
|
67.45 | - | 65.94 | 58.02 |
| Basic Earnings Per Share |
4.00%
-0.48
|
-0.50 | - | -0.40 | -0.47 |
| Diluted Earnings Per Share |
4.00%
-0.48
|
-0.50 | - | -0.40 | -0.47 |
3.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):